The Osceola School District Board Workshop held on July 15, 2025, focused on the district's pharmacy strategy, particularly regarding the management of specialty prescriptions. The discussion highlighted the significant costs associated with specialty drugs, which account for about half of the district's pharmacy expenses, despite being utilized by only a small percentage of members.

Board members emphasized the importance of monitoring the net costs of these medications, which can vary based on sourcing—whether domestically or internationally—and the availability of rebates. The district's pharmacy benefit manager, Vantegra, plays a crucial role in analyzing drug costs daily, ensuring that the district secures the most cost-effective options for its members.

A key point raised during the meeting was the impact of rebates on overall costs. While rebates can provide financial relief, their variability means that the district must continuously reassess its strategies to ensure sustainability. The board discussed the need for members to utilize preferred pharmacies, such as CVS and Walgreens, which offer lower dispensing fees compared to larger chains.

The workshop also touched on the increasing use of GLP-1 medications for diabetes and weight management, prompting the board to implement cost controls to ensure these drugs are prescribed appropriately. The district is committed to guiding members toward the most advantageous options while maintaining a focus on cost-effectiveness.

In conclusion, the Osceola School District is actively refining its pharmacy strategy to manage specialty drug costs effectively, leveraging daily analyses and encouraging the use of preferred pharmacies to benefit both the district and its members. The ongoing evaluation of rebates and sourcing strategies will be critical in maintaining financial sustainability in the face of rising pharmaceutical costs.